| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6170448 | The Breast | 2011 | 8 Pages |
Abstract
The CD44+CD24â group is considered a favorable prognostic subgroup in breast cancer. CD24 expression was a poor prognosis marker in hormone receptor positive breast cancer, and CD44 expression was a good prognostic marker in the receptor negative group.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Hee Jeong Kim, Mi-Jung Kim, Sei Hyun Ahn, Byung Ho Son, Sung Bae Kim, Jin Hee Ahn, Woo Chul Noh, Gyungyub Gong,